These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 15499699

  • 21. Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
    Mocroft A, Phillips AN, Ledergerber B, Katlama C, Chiesi A, Goebel FD, Knysz B, Antunes F, Reiss P, Lundgren JD.
    AIDS; 2006 May 12; 20(8):1141-50. PubMed ID: 16691065
    [Abstract] [Full Text] [Related]

  • 22. Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.
    Mouroux M, Descamps D, Izopet J, Yvon A, Delaugerre C, Matheron S, Coutellier A, Valantin MA, Bonmarchand M, Agut H, Massip P, Costagliola D, Katlama C, Brun-Vezinet F, Calvez V.
    Antivir Ther; 2001 Sep 12; 6(3):179-83. PubMed ID: 11808752
    [Abstract] [Full Text] [Related]

  • 23. Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.
    Crespo M, Ribera E, Suárez-Lozano I, Domingo P, Pedrol E, López-Aldeguer J, Muñoz A, Viladés C, Sánchez T, Viciana P, Teira R, García-Alcalde ML, Vergara A, Lozano F, Galindo MJ, Cosin J, Roca B, Terrón A, Geijo P, Vidal F, Garrido M, VACH Cohort Study Group.
    J Antimicrob Chemother; 2009 Jan 12; 63(1):189-96. PubMed ID: 18988678
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir.
    Villalba N, Gómez-Cano M, Casas E, Soriano V, Valencia E, González-Lahoz J.
    AIDS; 1997 Dec 12; 11(15):1896-7. PubMed ID: 9412717
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Abacavir: new preparation. Risks limit the value.
    Prescrire Int; 2000 Jun 12; 9(47):67-9. PubMed ID: 11010740
    [Abstract] [Full Text] [Related]

  • 29. Ongoing open-label trials of triple therapy with stavudine and lamivudine or stavudine and didanosine plus nelfinavir.
    Anderson RD.
    Antivir Ther; 1998 Jun 12; 3 Suppl 4():63-4. PubMed ID: 10723514
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
    Prescrire Int; 2008 Aug 12; 17(96):135-7. PubMed ID: 19480091
    [Abstract] [Full Text] [Related]

  • 32. Focusing on the second phase of plasma HIV-1 RNA clearance.
    Lafeuillade A, Poggi C, Sayada C, Pellegrino P, Profizi N.
    AIDS; 1997 Feb 12; 11(2):264-6. PubMed ID: 9030385
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. ddI and d4T plus protease inhibitors.
    GMHC Treat Issues; 1996 Nov 12; 10(11):8-9. PubMed ID: 11364012
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
    Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK, 903 Study Group.
    JAMA; 2004 Jul 14; 292(2):191-201. PubMed ID: 15249568
    [Abstract] [Full Text] [Related]

  • 36. New questions about an old combination--ddI + d4T.
    Proj Inf Perspect; 2003 Jan 14; (35):13-4. PubMed ID: 12647675
    [Abstract] [Full Text] [Related]

  • 37. Contraindicated antiretroviral drug combinations.
    Macher A, Thomas D, Paul SM.
    N J Med; 2003 Sep 14; 100(9 Suppl):41-3; quiz 73-4. PubMed ID: 14556602
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Evaluation of antiretroviral therapy in HIV-infected adults in the Department of Haematology, University Hospital of Brazzavllle, Congo].
    Dokekias AE, Galiba FO, Bokilo AD, Ntsimba P, Nsitou MB, Malanda F, Basseila GB.
    Bull Soc Pathol Exot; 2008 Apr 14; 101(2):109-12. PubMed ID: 18543703
    [Abstract] [Full Text] [Related]

  • 40. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
    Aguirrebengoa K, Mallolas J, Uriz J, Torres Tortosa M.
    Enferm Infecc Microbiol Clin; 1996 Oct 14; 14 Suppl 1():3-9. PubMed ID: 9053024
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.